학술논문

Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAF(V600 )mutation-positive melanoma

Document Type
Journal
Source
ANNALS OF ONCOLOGY; MAY 2022, 33 5, p544-p555, 12p.
Subject
Language
English
ISSN
15698041